The following video is from Thursday's Investor Beat, in which host Chris Hill and analysts Andy Cross and Matt Koppenheffer dissect the hardest-hitting investing stories of the day.
Shares of Costco (NASDAQ: COST ) hit an all-time high on Thursday, after the retailer reported a 19% increase in third-quarter profits. Costco racked up strong sales in both its domestic and international stores. What's behind Costco's success? Will the retailer continue to be a big hit with investors? In this installment of Investor Beat, Andy and Matt discuss the future of Costco.
Costco's low prices haven't just benefited customers -- shares have walloped the market, returning 11,000% over the past two decades. However, with prices at all-time highs, is the ride over for Costco investors? To answer that and more, The Motley Fool's compiled a premium research report with in-depth analysis on Costco.�Simply click here now to gain instant access to this valuable investor's resource.
10 Best Healthcare Technology Stocks To Buy For 2015: Danaher Corp (DHR)
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company�� research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. In April 2011, the Company sold its Pacific Scientific Aerospace (PSA) business. On June 30, 2011, the Company acquired Beckman Coulter, Inc. (Beckman Coulter). In January 2012, the Company sold its Accu-Sort businesses. In February 2012, the Company sold its Kollmorgen Electro-Optical (KEO) business. During the year ended December 31, 2011, the Company acquired EskoArtwork, On February 6, 2012, L-3 Communications Holdings, Inc. acquired Kollmorgen Electro-Optical unit of the Company. In January 2013, the Company acquired Navman Wireless.
TEST & MEASUREMENT
The Company�� Test & Measurement segment is a provider of electronic measurement instruments and monitoring, management and optimization tools for communications and enterprise networks and related services. The segment�� products are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and communications networks and services. Customers for these products and services include manufacturers of electronic instruments; service, installation and maintenance professionals; manufacturers who design, develop, manufacture and install network equipment, and service providers who implement, maintain and manage communications networks and services.
The Company�� business designs, manufactures, and markets a variety of compact professional test tools, thermal imaging and calibration equipment for electrical, industrial, electronic and calibration applications. These test products measure voltage, current, resistance, power quality, frequency, p! ressure, temperature and air quality. Typical users of these products include electrical engineers, electricians, electronic technicians, medical technicians, and industrial maintenance professionals. Its business also offers general purpose test products and video test, measurement and monitoring products used in electronic design, manufacturing and advanced technology development. The business��general purpose test products, including oscilloscopes, logic analyzers, signal sources and spectrum analyzers, are used to capture, display and analyze streams of electrical data. The Company sells these products into a variety of industries with electronic content, including the communications, computer, consumer electronics, education, military/aerospace and semiconductor industries.
Typical users include research and development engineers who use its general purpose test products to design, de-bug, monitor and validate the function and performance of electronic components, subassemblies and end-products. Its video test products include waveform monitors, video signal generators, compressed digital video test products and other test and measurement equipment used to enhance a viewer�� video experience. Typical users of these products include video equipment manufacturers, content developers and traditional television broadcasters. Products in this business are marketed under the FLUKE, TEKTRONIX, KEITHLEY, RAYTEK, FLUKE BIOMEDICAL, AMPROBE and MAXTEK brands.
The communications businesses offer network management solutions, handheld and fixed diagnostic equipment and security solutions, as well as related installation and maintenance services, for a range of private network applications, as well fixed and mobile communications systems. Typical users of the business��products include network engineers, installers, operators, and technicians. Its network management tools help network operators continuously manage network performance and optimize the utilization, uptime and servi! ce qualit! y of the network. Products in this business are marketed under the TEKTRONIX, FLUKE NETWORKS, ARBOR, VISUAL NETWORKS and AIRMAGNET brands.
Matco Tools manufactures and distributes professional tools, toolboxes and automotive equipment through independent mobile distributors, who sell primarily to professional mechanics under the MATCO brand. Hennessy Industries is a North American full-line wheel service equipment manufacturer, providing brake lathes, vehicle lifts, tire changers, wheel balancers, and wheel weights under the AMMCO, BADA and COATS brands. Typical users of these products are automotive tire and repair shops. Sales are generally made through its direct sales personnel, independent distributors, retailers, and original equipment manufacturers.
ENVIRONMENTAL
The Company�� Environmental segment provides products that help protect its water supply and air quality and serves two primary markets: water quality and retail/commercial petroleum. Danaher�� water quality business is engaged in water quality analysis and treatment, providing instrumentation and disinfection systems to help analyze and manage the quality of ultra pure, potable and waste water in residential, commercial, industrial and natural resource applications. Its water quality operations design, manufacture and market a range of analytical instruments, related consumables, and associated services that detect and measure chemical, physical, and microbiological parameters in ultra pure, potable and waste water as well as groundwater and ocean bodies; ultraviolet disinfection systems, which disinfect billions of gallons of municipal, industrial and consumer water every day in more than 35 countries, and industrial water treatment solutions, including chemical treatment solutions intended to address corrosion, scaling and biological growth problems in boiler, cooling water and industrial waste water applications, as well as associated analytical services. Typical users of its analytical in! struments! , ultraviolet disinfection systems, industrial water treatment solutions and related consumables and services include professionals in municipal drinking water and waste water treatment plants and industrial process water and waste water treatment facilities, third-party testing laboratories and environmental field operations. Its water quality business provides products under a variety of well-known brands, including HACH, HACH/LANGE, TROJAN TECHNOLOGIES and CHEMTREAT. Manufacturing facilities are located in North America, Europe, and Asia.
The Company has served the retail/commercial petroleum market through its Veeder-Root business. Gilbarco Veeder-Root is a provider of products and services for the retail/commercial petroleum market, including environmental monitoring and leak detection systems; vapor recovery equipment; fuel dispensers; point-of-sale and secure electronic payment technologies for retail petroleum stations; submersible turbine pumps, and remote monitoring and outsourced fuel management services, including compliance services, fuel system maintenance, and inventory planning and supply chain support. Typical users of these products include independent and Company-owned retail petroleum stations, high-volume retailers, convenience stores, and commercial vehicle fleets. The Company markets its retail/commercial petroleum products under a variety of brands, including GILBARCO, VEEDER-ROOT, and GILBARCO AUTOTANK. Manufacturing facilities are located in North America, Europe, Asia and Latin America. Sales are generally made through independent distributors and its direct sales personnel.
LIFE SCIENCES & DIAGNOSTICS
The Company�� diagnostics businesses offer a range of analytical instruments, reagents, consumables, software and services that hospitals, physician�� offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. Its life sciences businesses offer a range of research and clinical ! tools tha! t are used by scientists to study cells and cell components to gain a better understanding of complex biological matters. Pharmaceutical and biotechnology companies, universities, medical schools and research institutions use these tools to study the causes of disease, identify new therapies and test new drugs and vaccines. The diagnostics business consists of its core lab, acute care and pathology diagnostics businesses.
The Company�� core lab diagnostics business is a manufacturer and marketer of biomedical testing instrument systems, tests and supplies that are used to evaluate and analyze samples made up of body fluids, cells and other substances. The information generated is used to diagnose disease, monitor and guide treatment and therapy, assist in managing chronic disease and assess patient status in the hospital, outpatient and physician office settings. Its chemistry systems use electrochemical detection and chemical reactions with patient samples to detect and quantify substances of diagnostic interest in blood and other body fluids. Commonly performed tests include glucose, cholesterol, triglycerides, electrolytes, proteins and enzymes.
The Company�� immunoassay systems also detect and quantify chemical substances of diagnostic interest in body fluids, particularly in circumstances where more specialized diagnosis is required. Commonly performed immunoassay tests assess thyroid function, screen and monitor for cancer and cardiac risk and provide important information in fertility and reproductive testing. Its cellular analysis business includes hematology, flow cytometry and coagulation products. The business��hematology systems use principles of physics, optics, electronics and chemistry to separate cells of diagnostic interest and then quantify and characterize them, allowing clinicians to study formed elements in blood (such as red and white blood cells and platelets). The business also distributes coagulation products, which rely on clotting, chromogenic! and immu! nologic technologies to provide the detailed information that clinicians require to diagnose bleeding and clotting disorders and to monitor anticoagulant therapy. It also offer systems and workflow solutions that allow laboratories to automate a number of steps from the pre-analytical through post-analytical stages including sample barcoding/information tracking, centrifugation, aliquotting, storage and conveyance. These systems along with the analyzers above are controlled through laboratory level software that enables laboratory managers to monitor samples, results and lab efficiency.
The Company�� acute care diagnostics business is a provider of instruments and related consumables and services that are used in both laboratory and point-of-care environments to rapidly measure critical parameters, including blood gases, electrolytes, metabolites and cardiac markers. Typical users of these products include hospital central laboratories, intensive care units, hospital operating rooms and hospital emergency rooms. Its pathology diagnostics business is engaged in the anatomical pathology market, offering a suite of instrumentation and related consumables used across the entire workflow of a pathology laboratory. Its pathology diagnostics products include tissue embedding, processing and slicing (microtomes) instruments and related reagents and consumables; chemical and immuno-staining instruments, reagents, antibodies and consumables; slide coverslipping and slide/cassette marking instruments, and imaging instrumentation including slide scanners, microscopes, cameras and associated software. Typical users of these products include pathologists, lab managers and researchers. Its diagnostics business generally markets its products under the BECKMAN COULTER, LEICA BIOSYSTEMS, RADIOMETER and SURGIPATH brands. Manufacturing facilities are located in North America, Europe, Asia and Australia. The businesses sell to customers primarily through direct sales personnel and to a lesser extent through ! independe! nt distributors.
The Company�� microscopy business is a provider of professional microscopes designed to manipulate, preserve and capture images of, and enhance the user�� visualization of, microscopic structures. Its microscopy products include laser scanning (confocal) microscopes; compound microscopes and related equipment; surgical and other stereo microscopes; specimen preparation products for electron microscopy; and digital image capture and manipulation equipment. The Company also offers workflow instruments and consumables that help researchers analyze genomic, protein and cellular information. Key product areas include sample preparation equipment, such as centrifugation and capillary electrophoresis instrumentation and consumables; liquid handling automation instruments and associated consumables; flow cytometry instrumentation and associated antibodies and reagents; and particle characterization instrumentation. The business also offers genome profiling services. Researchers use the business��products to study biological function in the pursuit of basic research, therapeutic and diagnostic development. Typical users of these products include pharmaceutical and biotechnology companies, universities, medical schools and research institutions and in some cases industrial manufacturers.
The Company�� mass spectrometry business is a provider of high-end mass spectrometers. Mass spectrometry is a technique for identifying, analyzing and quantifying elements, chemical compounds and biological molecules, individually or in complex mixtures. Its products utilize various combinations of quadrupole, time-of-flight and ion trap technologies, and are typically used in conjunction with a third party liquid chromatography instrument. Its mass spectrometer systems are used in numerous applications, such as drug discovery and clinical development of therapeutics as well as in basic research, clinical testing, food and beverage quality testing and environmental testing. To s! upport it! s installations around the world, it provides implementation, validation, training, maintenance and support from its global services network. Typical users of its mass spectrometry products include molecular biologists, bioanalytical chemists, toxicologists, and forensic scientists, as well as quality assurance and quality control technicians. It also provides high-performance bioanalytical measurement systems, including microplate readers, automated cellular screening products and associated reagents, and imaging software. Typical users of these products include biologists and chemists engaged in research and drug discovery, who use these products to determine electrical or chemical activity in cell samples. Its life sciences business generally markets its products under the LEICA MICROSYSTEMS, BECKMAN COULTER, AB SCIEX and MOLECULAR DEVICES brands. Manufacturing facilities are located in Europe, Australia, Asia and North America.
DENTAL
The Company�� Dental segment is a provider of a range of consumables, equipment and services for the dental market, which encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its dental businesses develop, manufacture and market dental consumables and dental equipment orthodontic bracket systems and lab products; impression, bonding and restorative materials; endodontic systems and related consumables; infection prevention products, and diamond and carbide rotary instruments. Typical customers and users of these products include general dentists, dental specialists, dental hygienists, dental laboratories and other oral health professionals, as well as educational, medical and governmental entities. Its dental products are marketed primarily under the KAVO, GENDEX, iCAT, INSTRUMENTARIUM DENTAL, SOREDEX, PELTON & CRANE, DEXIS, ORMCO, KERR, PENTRON, SYBRON ENDO and TOTAL CARE brands.
INDUSTRIAL TECHNOLOGIES
The Company�� Industrial Technologies segment ! designs a! nd manufactures components and systems that are typically incorporated by original equipment manufacturers (OEMs) and systems integrators for sale into a diverse set of applications and end-markets. The businesses in this segment also provide service and support, including helping customers with integration and installation and providing services to ensure performance and up-time. Danaher�� product identification business is a global provider of equipment and consumables for variable printing, marking and coding on a variety of consumer and industrial products. Its businesses design, manufacture, and market a variety of equipment used to print bar codes, date codes, lot codes, and other information on primary and secondary packaging. Its equipment can apply alphanumeric codes, logos and graphics to a range of surfaces at a variety of line speeds, angles and locations on a product or package.
EskoArtwork, the business is a service solutions provider for the digital packaging design and production market. Typical users of the product identification business��products include food and beverage manufacturers, pharmaceutical manufacturers, retailers and commercial printing and mailing operations. Its product identification products are primarily marketed under the VIDEOJET, LINX, FOBA and ESKOARTWORK brands. Manufacturing facilities are located in North America, Europe, Latin America, and Asia. The Company is a provider of electromechanical motion control solutions for the industrial automation and packaging markets. Its businesses provide a range of products including standard and custom motors; drives; controls, and mechanical components, such as ball screws, linear bearings, clutches/brakes, and linear actuators.
The products are sold in various precision motion markets, such as the markets for packaging equipment, medical equipment, robotics, circuit board assembly equipment, elevators and electric vehicles (such as lift trucks). Its motion products are marketed under a vari! ety of br! ands, including KOLLMORGEN, THOMSON, DOVER and PORTESCAP. Manufacturing facilities are located in North America, Europe, Latin America, and Asia. Its sensors and controls products include instruments that monitor, sense and control discrete manufacturing variables such as temperature, position, quantity, level, flow and time. Users of these products span a wide variety of manufacturing markets. Certain businesses included in this group also make and sell instruments, controls and monitoring systems used by the electric utility industry to monitor their transmission and distribution systems, as well as automatic identification solutions. The products are marketed under a variety of brands, including DYNAPAR, HENGSTLER, IRIS POWER, WEST, GEMS SENSORS, SETRA and QUALITROL. Sales are generally made through our direct sales personnel and independent distributors.
The Company�� defense business designs, manufactures, and markets energetic material systems. Typical users of these products include defense systems integrators and prime contractors. defense products are typically marketed under the PACIFIC SCIENTIFIC ENERGETIC MATERIALS COMPANY brand. The KEO business designs, develops, manufactures and integrates highly engineered, stabilized electro-optical/ISR systems that integrate into submarines, surface ships and ground vehicles. Jacobs Vehicle Systems (JVS) is a supplier of supplemental braking systems for commercial vehicles, selling JAKE BRAKE brand engine retarders for class 6 through 8 vehicles and bleeder and exhaust brakes for class 2 through 7 vehicles. Customers are primarily manufacturers of class 2 through class 8 vehicles, and sales are typically made through its direct sales personnel. Manufacturing facilities of its sensors and controls, defense and JVS businesses are located in North America, Latin America, Europe and Asia.
Advisors' Opinion:- [By Ben Levisohn]
General Electric’s industrial units hummed along. It announced plans to shed it consumer-finance business. And its shares, which returned 37% in 2013, kept pace with Danaher (DHR) and United Technologies (UTX), even if they lagged 3M’s (MMM) 54% gain.
- [By Muhammad Bazil]
3M�� performance comes off as okay when viewed against other industrial conglomerates that have already posted their 2nd quarter results; at least as far as growth is concerned. The company�� 2.3% organic growth in the second quarter compares well to conglomerates such as United Technologies (UTX), General Electric (GE), Danaher (DHR) and Honeywell (HON).
- [By Ben Levisohn]
Intuitive Surgical has fallen 4.4% to $381.39 today, but doesn’t seem to be having much of an impact on comparable companies. Hologic (HOLX) has ticked up 0.2% to $22.06, Danaher (DHR) has fallen -.4% to $72.05 and Varian Medical Systems (VAR) has gained 0.2% to $78.70.
- [By Teresa Rivas]
Danaher (DHR) and Waters Corporation (WAT) were mirror images of one another, with the former rising 1.3% at recent check and the latter falling by 1.3%.
The disparate moves come as Goldman Sachs weighed in on both names, upgrading Danaher to Buy and downgrading Waters to Neutral.
Analyst Isaac Ro and his team write that while Danaher has outperformed since the summer, they are confident it can continue to beat the broader market, given accelerating growth the potential for EPS accretion, based on the company�� possible capital allocation strategies.
They see three main catalysts that could spur the stock next year:
(1) Tailwinds in Healthcare are underestimated by the Street: We anticipate continued share gains in AB SCIEX and Beckman, buttressed by a new product cycle (DxN) in 2014/2015. In Dental, we are encouraged by 3Q commentary among peers along with improving consumer spending patterns. We look for updates at the Greater NY Dental Meeting (December 1-4).
(2) Positive set-up in Industrial segments: We believe a positive 2014 outlook from Multi-Industry peers combined with easing 2014 comps in IT/T&M/Environmental present a favorable set-up.
(3) Capital deployment likely near term: We believe a sizable transaction is a near-term possibility, as 76% of capital deployed for acquisitions over $500mn since 2000 has taken place when net debt/EBITDA was below 0.75x, and DHR should exit 2013 at 0.2x. Our M&A and share repurchase scenario analyses yield 2014E EPS accretion of 4-12%. We look for an update on capital deployment at the Investor Meeting on December 12.
Ro and his team have an $88 price target on the stock.
By contrast, they downgraded Waters, writing that their previous bullish thesis was based on improved demand for the company�� quality assurance and quality control products, recovery of market share through new product cycles and potential for M&A activity. However, while they s
10 Best International Stocks To Invest In 2014: Spdr S&P Homebuilders Etf (XHB)
SPDR S&P Homebuilders ETF (the Fund) seeks to replicate as closely as possible, before expenses, the performance of the S&P Homebuilders Select Industry Index (the Index). To accomplish this, the Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks intended to replicate the Index.
The S&P Homebuilders Select Industry Index seeks to provide a representation of the homebuilders��sub-industry portion of the S&P Total Market Index. The S&P TMI tracks all the United States common stocks regularly traded on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap Exchanges. The Homebuilders Index is an equal weighted market cap index.
Advisors' Opinion:- [By Ben Levisohn]
The SPDR S&P Homebuilders ETF (XHB) has dropped 10.5% during the past three months, or about when all the talk about an end to the Fed’s bond buying really picked up, compared to a 2.7% return for the S&P 500.
- [By John Maxfield]
Meanwhile, housing is feeling the effects via higher mortgage rates. For portions of last year, a 30-year conventional mortgage carried an interest rate of less than 3.5%. Since the Fed's announcements, the same rate has climbed back to more than 4%. This is sending shivers through homebuilders' stocks, as the net effect is to make homes more expensive. The SPDR S&P Homebuilders (NYSEMKT: XHB ) ETF, which tracks the housing sector, is down almost 9% since May 22.
- [By Anora Mahmudova]
The day�� economic data provided a little support. The sales pace of existing homes ticked down in March to the slowest rate since July 2012, according to data released Tuesday, however the decline was smaller than the consensus rate forecast by economists polled by MarketWatch. The SPDR S&P Homebuilder ETF (XHB) �gained 1%.
- [By Jon C. Ogg]
1. The U.S. economy grows 3% as housing starts surpass one million and private employment hits an all-time high – All time high on private employment? 1 million housing starts?
Homebuilder ETF: SPDR S&P Homebuilders ETF (NYSEArca: XHB) as it is tied to homebuilders and building products rather than including other sectors that only overlap in building. At $32.57, its 52-week range is 426.94 to $33.38. Housing Starts were always well over 1 million on an annualized basis each month before the recession, but they only reached that in two months of 2013 (St. Louis Fed data).2. 10-Year Treasury yields move toward 3.5% as the Federal Reserve completes tapering and holds short-term rate near zero – This may sound bad, but it is actually good and fits in line with rates not rising too much. Keep in mind that the 10-year Treasury is at 2.94% now and ended at 3.03% on the last day of 2013. Elsewhere on the yield curve, Doll sees many parts of the fixed income market to end 2014 with negative total rates of return.
10 Best International Stocks To Invest In 2014: ICG Group Inc (ICGE)
ICG Group, Inc. (ICG), formerly Internet Capital Group, Inc., acquires and builds Internet software and services companies. ICG operates in two business segments: the core reporting segment and the venture reporting segment. The Company�� core reporting segment includes those companies in which its management provides strategic direction and management assistance. Its venture reporting segment includes companies to which it generally devote less capital than it does to its core companies and, therefore, in which it holds relatively smaller ownership stakes than it does in the core companies. As of December 31, 2011, its equity core companies consisted of Channel Intelligence, Inc., Freeborders, Inc. and WhiteFence, Inc. As of December 31, 2011, its venture companies consisted of Acquirgy, Inc., GoIndustry-DoveBid plc and SeaPass Solutions Inc. In April 2012, it acquired MSDSonline Inc. In December 2012, the Company aquired 85% of interest in Procurian Inc. In February 2013, Google Inc acquired Channel Intelligence, Inc. one of the consolidated companies of ICG.
The Company is focused on the software and services markets, particularly on companies in the cloud-based software and services sector. Once the Company acquires an interest in a company, it works to assume an active role in the development and growth of the Company, providing both strategic guidance and operational support. The Company provides strategic guidance to its companies relating to, among other things, market positioning, business model and product development, strategic capital expenditures, mergers and acquisitions and exit opportunities. In addition, it provides operational support to help its companies manage day-to-day business and operational issues and implement the practices in the areas of finance, sales and marketing, business development, human resources and legal services.
GovDelivery Holdings, Inc.
GovDelivery Holdings, Inc. (GovDelivery) is a provider of government-to-citizen com! munication solutions. GovDelivery�� digital subscription management software-as-a-service (SaaS) platform enables government organizations to provide citizens with access to relevant information by delivering new information through e-mail, mobile text alerts, really simple syndication (RSS) and social media channels from United States and United Kingdom government entities at the national, state and local levels.
Investor Force Holdings, Inc.
Investor Force Holdings, Inc. (InvestorForce) is a financial software company specializing in the development of online applications for the financial services industry. InvestorForce provides pension consultants and other financial intermediaries with a Web-based enterprise platform that integrates data management with robust analytic and reporting capabilities in support of their institutional and other clients. InvestorForce�� applications provide investment consultants with the ability to conduct analysis and research into client, manager and market movement and to produce timely, automated client reports.
Procurian Inc.
Procurian Inc. (Procurian) is a specialist in procurement solutions, which partners with transformational business to drive sustainable changes to their cost structures on an accelerated basis. Procurian integrates superior market intelligence with its customers��businesses to optimize spending and deliver savings.
Channel Intelligence, Inc.
Channel Intelligence, Inc. (Channel Intelligence) is a technology and marketing services company that helps retailers, manufacturers and other advertisers make their products and services easier for consumers to find and buy online and in local retail stores. Through its technologies and product database, Channel Intelligence offers online marketing services, such as display advertising, manufacturer-based content and where-to-buy, paid search, shopping engine management, social marketing, Web storefronts, order manage! ment and ! robust performance analytics. With its range of services, Channel Intelligence helps its customers support their consumers through all phases of the sales funnel, from lead generation to consideration to purchase and delivery.
WhiteFence, Inc.
WhiteFence, Inc. (WhiteFence) is a Web services provider used by household consumers to compare and purchase essential home services, such as electricity, natural gas, telephone and cable/satellite television. WhiteFence reaches customers directly through company-owned Websites and through its network of exclusive channel partners that integrate the Web services applications into their own business processes and Websites.
Acquirgy, Inc.
Acquirgy, Inc. (Acquirgy) specializes in direct response marketing services and technology, which provides customers with a range of direct marketing products and services. Acquirgy helps market its products and services on the Internet and through other media channels, such as television, radio, and print advertising.
GoIndustry-DoveBid plc (GoIndustry)
GoIndustry-DoveBid plc (GoIndustry) is an in auction sales and valuations of used industrial machinery and equipment. GoIndustry combines traditional asset sales experience with e-commerce technology and advanced direct marketing to service the needs of multi-national corporations, insolvency practitioners, dealers and asset-based lenders worldwide.
SeaPass Solutions Inc.
SeaPass Solutions Inc. (SeaPass) develops and markets processing solutions that enables insurance carriers, agents and brokers to transmit and receive data in real time by leveraging existing systems to interact automatically. The Company�� technology allows information to be accessed in real time, which increases efficiency across all lines of the insurance business.
Advisors' Opinion:- [By Jake L'Ecuyer]
ICG Group (NASDAQ: ICGE) was also up, gaining 9.77 percent to $15.39 after the company announced the sale of Procurian to Accenture plc (NYSE: ACN) for $375 million in cash.
10 Best International Stocks To Invest In 2014: C&C Group PLC (CCGGY)
C&C Group plc, incorporated on March 19, 2004, is engaged the production, marketing and selling of cider and beer. The Company operates in five segments: Republic of Ireland (ROI), Cider United Kingdom (Cider UK), Tennent�� United Kingdom (Tennent�� UK), International, and Third Party Brands United Kingdom (Third Party Brands UK). The Company�� cider brands include Bulmers, Magners, Gaymers Cider, Blackthorn Cider, Olde English, Addlestones, Woodchuck Hard Cider, Wyder�� Cider and Hornsby��. Its other cider brands include Bulmers Berry, Bulmers Pear, Magners Pear, Magners Specials, Special Vat, K, Natch and Diamond White.
ROI includes the results from sale of all products in the Republic of Ireland (ROI), including Bulmers, Tennent��, Caledonia Smooth and third party brands. Cider UK segment includes the results from sale of the Company�� cider products in the United Kingdom, with Magners, Gaymers and Blackthorn the principal brands. Tennent�� UK segment includes the results from sale of the Company�� owned beer brand Tennent�� in the United Kingdom and sales of Caledonia Best in the United Kingdom. International segment includes the results from sale of the Company�� cider and beer products, principally Magners, Blackthorn, Hornsby��, Woodchuck and Tennent�� in all territories outside of the ROI and the United Kingdom. Third Party Brands UK segment relates to the distribution of third party brands and the production and distribution of private label products in the United Kingdom.
Advisors' Opinion:- [By Rich Duprey]
The growth in 2012 follows the success of hard cider sales the year before, which saw a 40% increase. Yet the industry leader remains C&C Group's (NASDAQOTH: CCGGY ) Vermont Hard Cider, whose Woodchuck Hard Cider has a 41% share of the market, though analysts say Angry Orchard owns nearly half of the on-premises market at the end of the first quarter.
- [By Rich Duprey]
At C&C Group's (NASDAQOTH: CCGGY ) annual meeting earlier this month, it was revealed that when it bought the Hornsby brand two years ago, it paid $25 million and got a 20% share of the market for its efforts. It paid more than 10 times that amount, or about $300 million, for Vermont Hard Cider and its top Woodchuck brand, and got another 42% share of the market. So C&C had almost two-thirds of the cider market all to itself.
- [By Rich Duprey]
While�Anheuser-Busch InBev (NYSE: BUD ) introduced some fruit-flavored margarita drinks and even Beam offered flavored bourbons to water down the market more,�the bigger threat may be coming from the explosive growth being witnessed in�hard cider.�Brewer Boston Beer (NYSE: SAM ) rolled out its Angry Orchard cider brand just last year and has already catapulted to the top of the market, surpassing C&C Group's (NASDAQOTH: CCGGY ) Vermont Hard Cider, the previous market leader.
10 Best International Stocks To Invest In 2014: UBS AG (UBSN)
UBS AG, incorporated on February 28, 1978, is a client-focused financial services company that offers a combination of wealth management, asset management and investment banking services on a global and regional basis. UBS AG is the parent company of the UBS Group (Group).The operational structure of the Company consists of the Corporate Center and four business divisions: Wealth Management & Swiss Bank, Wealth Management Americas, Global Asset Management and the Investment Bank. As of December 31, 2011, the Company operated about 877 business and banking locations worldwide, of which about 42% were in Switzerland, 42% in the Americas, 11% in the rest of Europe, Middle East and Africa, and 5% in Asia-Pacific. During the year ended December 31, 2011, it completed acquisitions in Global Asset Management and in the equities business of the Investment Bank. In November 2011, investment management responsibility for a private equity fund of funds was transferred to Global Asset Management from Wealth Management & Swiss Bank. In October 2011, Global Asset Management acquired ING Investment Management Limited business in Australia. In July 2011, the infrastructure and private equity fund of funds businesses were transferred from its alternative and quantitative investment area to its infrastructure investment area. In January 2011, investment management responsibility for a multi-manager alternative fund was transferred to Global Asset Management from Wealth Management & Swiss Bank.
Wealth Management
Wealth Management provides wealthy private clients with financial advice, products and tools to fit their individual needs. As of December 31, 2011, Wealth Management had presence in over 40 countries and approximately 200 wealth management and representative offices, half of which are outside Switzerland, mostly in Europe, Asia Pacific, Latin America and the Middle East. During 2011, the Company had CHF 750 billion of invested assets. The Company offers products and services to private! clients, focusing in particular on the ultra-high-net-worth (clients with investable assets of more than CHF 50 million) and high-net-worth client segments (clients with investable assets between CHF 2 million and CHF 50 million). In addition, it also provides wealth management solutions, products and services to financial intermediaries. Wealth Management has a presence in over 40 countries and approximately 200 wealth management and representative offices, half of which are outside Switzerland, mostly in Europe, Asia Pacific, Latin America and the Middle East.
The Company�� Global Financial Intermediaries (Global FIM) business serves approximately 1,700 asset managers. It provides its clients with the financial advice, products and tools. The Company�� clients can trade a range of financial instruments from single securities, such as equities and bonds, to various investment funds, structured products and alternative investments. Additionally, it offers structured lending, corporate finance and wealth planning advice on client needs, such as funding for education, inheritance and succession. For its ultra high net worth clients, it offers institutional-like servicing that provides access to its Investment Bank and Global Asset Management offerings. Wealth Management also gives clients access to the knowledge, and product and service offerings from Global Asset Management and the Investment Bank, complemented by an open product platform providing access to an array of products from third-party providers.
The Company competes with Credit Suisse, Julius Bar, HSBC, Deutsche Bank, JP Morgan, Citigroup, Barclays and Unicredit.
Retail & Corporate
The Company delivers financial products and services to its retail, corporate and institutional clients. The Retail & Corporate unit is a core element of UBS Switzerland�� universal bank delivery model. As of December 31, 2011, the Company had a network of around 300 branches, 1,250 automated teller machines! , self-se! rvice terminals and customer service centers, alongside e-banking and mobile banking. The Company�� retail clients have access to offering, including cash accounts, payments, savings and retirement solutions, investment fund products, residential mortgages, as well as life insurance and advisory services. It provides financing solutions to its corporate clients, offering access to capital markets (equity and debt capital), syndicated and structured credit, private placements, leasing and traditional financing. The Company�� transaction banking offers solutions for payments and cash management services, trade and export finance, receivable finance, as well as global custody solutions to institutional clients.
The Company competes with Credit Suisse, Raiffeisen and PostFinance.
Wealth Management Americas
Wealth Management Americas provides advice-based relationships through its financial advisors, who deliver a range of wealth management solutions. On December 31, 2011, the business division had CHF 709 billion in invested assets. Wealth Management Americas consisted of branch networks in the United States, Puerto Rico and Canada, with 6,967 financial advisors as of 31 December 2011. Most corporate and operational functions of the business division are located in the home office in Weehawken, New Jersey. In the United States and Puerto Rico, Wealth Management Americas operates through direct and indirect subsidiaries of UBS AG. Securities and operations activities are conducted primarily through two broker-dealers, UBS Financial Services Inc. and UBS Financial Services Incorporated of Puerto Rico. Its banking services in the United States include those conducted through the UBS AG branches and UBS Bank USA, a federally regulated Utah bank, which provides Federal Deposit Insurance Corporation (FDIC) insured deposit accounts. It includes the domestic US business, the domestic Canadian business and international business booked in the United States.
Ca! nadian we! alth management and banking operations are conducted through UBS Bank (Canada). The Company�� include wealth accumulation and preservation, income generation and portfolio diversification. The Company�� advisors work closely with internal consultants in areas, such as wealth planning, portfolio strategy, retirement and annuities, alternative investments, managed structured products, banking and lending, equities, and fixed income accounts, structured products, banking and lending, equities, and fixed income retirement and annuities, alternative investments, managed accounts, structured products, banking and lending, equities, and fixed income. It also offers lending and cash management services, such as securities-backed lending, the resource management account, FDIC-insured deposits, mortgages and credit cards. For corporate and institutional clients, it offers a range of solutions, including equity compensation, administration, investment consulting, defined benefit and contribution programs and cash management services. It offers a range of equity and fixed income instruments.
The Company competes with Bank of America, Morgan Stanley and Wells Fargo.
Global Asset Management
The Company serves third-party institutional and wholesale clients and the clients of UBS�� wealth management businesses. The Company�� fund services unit, a global fund administration business, provides professional services, including legal fund set-up, accounting and reporting. Invested assets totaled CHF 574 billion and assets under administration were CHF 375 billion on December 31, 2011. Global Asset Management serves third-party institutional and wholesale clients, and the clients of UBS�� wealth management businesses. Global Asset Management�� business lines include traditional investments (equities, fixed income and global investment solutions); alternative and quantitative investments; global real estate; infrastructure and private equity, and fund services.
Global ! investment solutions offer asset allocation, currency, multi-manager, structured solutions, risk advisory and strategic investment advisory services. Alternative and quantitative investments has two primary business lines-Alternative Investment Solutions (AIS) and O��onnor. AIS offers a range of hedge fund solutions and advisory services, including multi-manager strategies. O��onnor is a provider of single-manager global hedge funds. Global real estate manages real estate investments globally and regionally within Asia, Europe, Switzerland and the United States. Infrastructure and private equity manages direct infrastructure investment and multi-manager infrastructure and private equity strategies for both institutional and high net worth investors. Infrastructure asset management manages direct investments in core infrastructure assets worldwide. Fund services, the global fund administration business, provides professional services, including legal set-up, reporting and accounting for retail and institutional investment funds, hedge funds and other alternative products.The Company competes with Fidelity Investments, AllianceBernstein Investments, BlackRock, JP Morgan Asset Management and Goldman Sachs Asset Management.
Investment Bank
The Investment Bank provides a range of products and services in equities, fixed income, foreign exchange and commodities to corporate and institutional clients, sovereign and government bodies, financial intermediaries, alternative asset managers and UBS�� wealth management clients. The Investment Bank has three business areas: equities, fixed income, currencies and commodities (FICC), and the investment banking department. The Company operates through branches and subsidiaries of UBS AG. Securities activities in the United States are conducted through UBS Securities LLC, a broker-dealer. Securities research provides investment analysis across a range of asset classes of more than 3,400 companies worldwide.
The ! Company p! articipates in the primary and secondary markets for cash equity and equity-related products, including listed options, structured products, equity-linked securities, swaps, futures and over-the-counter (OTC) derivative contracts. Cash equities provide clients with liquidity, investment advisory, trade execution and related consultancy services. It offers trade execution for single stocks and portfolios, including capital commitment, block trading, small-cap execution and commission management services. In addition, it also provides clients with a range of electronic trading algorithms and analytical tools. Derivatives and equity-linked provides a range of flow, structured, synthetic and equity-linked products with worldwide access to primary and secondary markets.
Prime services offer brokerage business, including clearing and custody, capital consultancy, financing, securities lending and equity swaps execution. The FICC business area delivers products and solutions to corporate, institutional and public-sector clients in all markets, as well as to private clients via targeted intermediaries. Macro consists of the foreign exchange, money market and interest rate sales and trading businesses, as well as cash and collateral trading. It provides a range of foreign exchange, precious metals, treasury, and liquidity management solutions to institutional and private clients via targeted intermediaries. Credit sales and trading consists of the origination, underwriting, trading and distribution of cash and synthetic products across the credit spectrum - bonds, derivatives, notes and loans.
The investment banking department provides advice and a range of capital markets execution services to corporate clients, financial institutions, financial sponsors, sovereign clients and hedge funds. The Company also provides liquidity in local markets across foreign exchange, credit, rates and structured products. The advisory group assists in acquisitions and sale processes, and also advises on! reviews ! and corporate restructuring solutions. Global capital markets is a joint venture with the securities business. It offers financing and advisory services that cover all forms of capital raising, as well as risk management solutions. Global leveraged finance provides event-driven (acquisition, leveraged buyout) loans, and bond and mezzanine leveraged finance to corporate clients and financial sponsors.
The Company competes with Bank of America/Merrill Lynch, Barclays Capital, Citigroup, Credit Suisse, Deutsche Bank, Goldman Sachs, JP Morgan Chase and Morgan Stanley.
Advisors' Opinion:- [By Bloomberg News]
��e believe land reform, free trade zones, national security, and state-owned enterprises may become long-lasting investment themes,��UBS AG (UBSN) strategist Chen Li, wrote in a report dated today. ��ousehold registration reform, population policy, and financial reform remain to be seen, and may have a short-term negative impact on related thematic investment in terms of sentiment.��
- [By Bloomberg News]
UBS AG (UBSN)�� China venture plans to offer more computerized-trading services as it bets on a surge in demand from institutional money managers in the biggest emerging market.
- [By Sofia Horta e Costa]
BP posted its best week in 23 months after the oil producer increased its dividend. Alcatel-Lucent rallied 18 percent after predicting it will beat its cost-cutting targets this year and reporting a narrower-than-forecast quarterly loss. UBS AG (UBSN) dropped the most in almost two years after saying it may fail to reach its profitability goal until at least 2016.
- [By Robert Wall]
Bookrunners for the sale are Goldman Sachs Group Inc., UBS AG (UBSN), Barclays Plc (BARC) and Merrill Lynch & Co., with Investec Ltd., Nomura Bank International Plc and RBC Europe Ltd. lead managers, said the government, which is being advised by Lazard Ltd. (LAZ)
10 Best International Stocks To Invest In 2014: Insulet Corporation(PODD)
Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
Advisors' Opinion:- [By James Brumley]
And just for the record, theme-based buyout speculation doesn’t improve your chances of picking an acquisition target. Back in 2012 after Bristol-Myers Squibb (BMY) bought Amylin for control of its diabetes pipeline following the purchase of Neighborhood Diabetes by Insulet (PODD), pundits were sure it would spark a wave of other diabetes-driven acquisitions. Those other M&A candidates began getting bid up, but as it turns out, no more meaningful buyouts materialized in the diabetes space.
- [By Rich Smith]
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of downgrades for document storage company Iron Mountain (NYSE: IRM ) and insulin treatments-equipment maker Insulet (NASDAQ: PODD ) . But the headlines aren't all bad, so before we break the bad news to you, let's start off on a bright note about...
10 Best International Stocks To Invest In 2014: Adelaide Resources Ltd (ADN)
Adelaide Resources Limited is an Australia-based company engaged in the exploration for gold, copper, uranium, and other economic mineral deposits. As on June 30, 2012, the Company has interests in 22 exploration licenses, covering over 7,800 square kilometers within South Australia, the Northern Territory and Queensland. The Company holds 100% of the majority of the Moonta Project on Yorke Peninsula in South Australia and a program of aircore and diamond drilling was completed in early 2012 to test a number of targets. The Company�� projects include Rover, Eyre Peninsula, Eyre Peninsula Basement, Yalanda Hill JV, Corrobinnie Palaeochannel Project, Cleve, Anabama, Moonta and Glenroy. The Company subsidiaries include Adelaide Exploration Pty Ltd and Peninsula Resources Limited (formerly Eyre Energy Pty Ltd) Advisors' Opinion:- [By Tom Stoukas]
Aberdeen Asset Management Plc (ADN), Scotland�� largest money manager, lost 7.9 percent to 368.5 pence as Goldman Sachs Group Inc. downgraded the stock to neutral from buy.
- [By Sofia Horta e Costa]
Aberdeen Asset Management Plc (ADN) dropped 1.7 percent to 415.7 pence, the lowest price in six weeks. Bank of America Corp.�� Merrill Lynch unit cut its rating on Scotland�� largest money manager to underperform, similar to a sell recommendation, from neutral, saying the stock�� price is unjustified given slowing earnings growth.
No comments:
Post a Comment